ArticleBlood advances2026
Low serum cholesterol is a biomarker of advanced disease and poor outcomes in myeloproliferative neoplasms.
Orly Leiva et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it